Fred Schwarzer - 04 Apr 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Apr 2023, 21:43:35 UTC
Prior SEC filing
20 Dec 2022
Next SEC filing
20 Apr 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Fred Schwarzer

Key filing fact

Fred Schwarzer filed Form 4 for IGM Biosciences, Inc. (IGMS) on 06 Apr 2023.

Key facts

  • This page summarizes Fred Schwarzer's Form 4 filing for IGM Biosciences, Inc. (IGMS).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 06 Apr 2023, 21:43.

Change

  • Previous filing in this sequence was filed on 20 Dec 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IGMS transaction

Common Stock

Award

Transaction value
$0
Shares
+67,500
Change %
+332%
Price
$0.000000
Shares after
87,860
Date
04 Apr 2023
Ownership
Direct
Footnotes
F1
IGMS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
196,718
Date
04 Apr 2023
Ownership
See footnote
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IGMS transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+135,000
Change %
Price
$0.000000
Shares after
135,000
Date
04 Apr 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
135,000
Exercise price
$12.86
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One-fourth of the RSUs shall vest on March 12, 2024 and each one-year anniversary thereafter, provided that the Reporting Person remains a service provider through each vesting date.

Footnote F2

The shares are held by Fred M. Schwarzer & Deborah R. Schwarzer TTEES of the Schwarzer Family Trust U/A DTD 04/05/2018.

Footnote F3

1/48 of the shares subject to the option shall vest on April 12, 2023 and each month thereafter, provided that the Reporting Person remains a service provider through each vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .